Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07JSI
|
|||
Former ID |
DNC001267
|
|||
Drug Name |
Salicylihalamide A
|
|||
Synonyms |
SCHEMBL2401788
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Preclinical | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C26H33NO5
|
|||
Canonical SMILES |
CCC=CC=CC(=O)NC=CCC1CC(C(CC=CCC2=C(C(=CC=C2)O)C(=O)O1)C)O
|
|||
InChI |
1S/C26H33NO5/c1-3-4-5-6-16-24(30)27-17-10-14-21-18-23(29)19(2)11-7-8-12-20-13-9-15-22(28)25(20)26(31)32-21/h4-10,13,15-17,19,21,23,28-29H,3,11-12,14,18H2,1-2H3,(H,27,30)/b5-4-,8-7+,16-6-,17-10+/t19-,21-,23+/m0/s1
|
|||
InChIKey |
VFCUJHFLFHQCRD-PFIOQAQVSA-N
|
|||
CAS Number |
CAS 198481-99-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Vacuolar-type proton ATPase (v-ATPase) | Target Info | Inhibitor | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Lysosomes as a therapeutic target. Nat Rev Drug Discov. 2019 Dec;18(12):923-948. | |||
REF 2 | Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases. J Pharmacol Exp Ther. 2001 Apr;297(1):114-20. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.